<p>1×10<sup>5</sup> 291 parental cells (291PC) and retrovirally transduced 291OVA cells were injected s.c. into IFN-γ-deficient (A) and into IFN-γ-receptor- and STAT1-deficient recipient mice (B). Survival (left panels) and corresponding cumulative tumor growth (right panels) were monitored over 100 days. The data are compiled from two independent experiments. (C) Lymphomas developing in IFN-γ-receptor- and STAT1-deficient mice after inoculation of 1×10<sup>5</sup> 291 parental or 291OVA cells were analyzed by immunohistochemistry for infiltration of CD3-positive cells (peroxidase brown staining) and perforin expressing cells (alkaline phosphatase staining) (left panel) in the same fashion as shown in <a href="http://www.plosone.org/article...
To study mechanisms of T cell-mediated rejection of B cell lymphomas, we developed a murine lymphoma...
To study mechanisms of T cell-mediated rejection of B cell lymphomas, we developed a murine lymphoma...
<p>Mice harboring subcutaneous B16.OVA tumors were treated intraperitoneally with 2x10<sup>6</sup> C...
<p>IFN-γ-receptor-deficient λ-huMYC lymphoma cells, either retrovirally transduced (50OVA) (solid li...
<p>Mice bearing syngeneic B16.OVA tumors were adoptively transferred with 2x10<sup>6</sup> CD8a<sup>...
<p>(A) Experimental design for competitive mixed BM chimeras using wild-type (WT) and <i>Ifnγr2</i> ...
<p>(A, B, D, F–H) Fibrosarcomas were induced in <i>Il27ra</i><sup>+/+</sup> (grey bars) and <i>Il27r...
To study mechanisms of T cell-mediated rejection of B cell lymphomas, we developed a murine lymphoma...
<p>B6 mice were treated with IFNαR1 antibody or its isotype and immunized with ID93+GLA-SE. Innate r...
Despite lack of tumor control in many models, spontaneous T cell priming occurs frequently in respon...
<p>WT MMC tumor cells were cultured with IFN-γ (50 ng/ml/10<sup>6</sup> cells) for two weeks and we...
<p>(A) CFSE labeled spleen cells from CD98hc<sup>f/f</sup>-CD4-OT11 or CD98hc<sup>+/+</sup>-CD4-OT11...
To study mechanisms of T cell-mediated rejection of B cell lymphomas, we developed a murine lymphoma...
<p>MNCs were isolated from spleen and liver samples of WT and IFN-γ<sup>−/−</sup> mice 8 weeks after...
<p>(A) Correlation of the frequency of IFN-γ-producing cells and tumor development. Tumor inoculatio...
To study mechanisms of T cell-mediated rejection of B cell lymphomas, we developed a murine lymphoma...
To study mechanisms of T cell-mediated rejection of B cell lymphomas, we developed a murine lymphoma...
<p>Mice harboring subcutaneous B16.OVA tumors were treated intraperitoneally with 2x10<sup>6</sup> C...
<p>IFN-γ-receptor-deficient λ-huMYC lymphoma cells, either retrovirally transduced (50OVA) (solid li...
<p>Mice bearing syngeneic B16.OVA tumors were adoptively transferred with 2x10<sup>6</sup> CD8a<sup>...
<p>(A) Experimental design for competitive mixed BM chimeras using wild-type (WT) and <i>Ifnγr2</i> ...
<p>(A, B, D, F–H) Fibrosarcomas were induced in <i>Il27ra</i><sup>+/+</sup> (grey bars) and <i>Il27r...
To study mechanisms of T cell-mediated rejection of B cell lymphomas, we developed a murine lymphoma...
<p>B6 mice were treated with IFNαR1 antibody or its isotype and immunized with ID93+GLA-SE. Innate r...
Despite lack of tumor control in many models, spontaneous T cell priming occurs frequently in respon...
<p>WT MMC tumor cells were cultured with IFN-γ (50 ng/ml/10<sup>6</sup> cells) for two weeks and we...
<p>(A) CFSE labeled spleen cells from CD98hc<sup>f/f</sup>-CD4-OT11 or CD98hc<sup>+/+</sup>-CD4-OT11...
To study mechanisms of T cell-mediated rejection of B cell lymphomas, we developed a murine lymphoma...
<p>MNCs were isolated from spleen and liver samples of WT and IFN-γ<sup>−/−</sup> mice 8 weeks after...
<p>(A) Correlation of the frequency of IFN-γ-producing cells and tumor development. Tumor inoculatio...
To study mechanisms of T cell-mediated rejection of B cell lymphomas, we developed a murine lymphoma...
To study mechanisms of T cell-mediated rejection of B cell lymphomas, we developed a murine lymphoma...
<p>Mice harboring subcutaneous B16.OVA tumors were treated intraperitoneally with 2x10<sup>6</sup> C...